Market closedNon-fractional
Baxter/BAX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Baxter
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
Ticker
BAX
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Deerfield, United States
Employees
60,000
Website
www.baxter.com
Baxter Metrics
BasicAdvanced
$18B
Market cap
6.73
P/E ratio
$5.22
EPS
0.57
Beta
$1.16
Dividend rate
3.31%
Dividend yield
Price and volume
Market cap
$18B
Beta
0.57
Dividend rate
$1.16
Financial strength
Current ratio
1.477
Quick ratio
0.88
Long term debt to equity
140.085
Total debt to equity
172.07
Dividend payout ratio (TTM)
22.16%
Interest coverage (TTM)
3.25%
Management effectiveness
Return on assets (TTM)
3.56%
Return on equity (TTM)
-0.42%
Valuation
Price to earnings (TTM)
6.726
Price to revenue (TTM)
1.194
Price to book
2.19
Price to tangible book (TTM)
-4.29
Price to free cash flow (TTM)
25.151
Dividend yield (TTM)
3.31%
Growth
Revenue change (TTM)
2.98%
Earnings per share change (TTM)
-207.04%
3-year revenue growth (CAGR)
8.01%
3-year earnings per share growth (CAGR)
36.10%
3-year dividend per share growth (CAGR)
5.78%
What the Analysts think about Baxter
Analyst Ratings
Majority rating from 17 analysts.
Baxter Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.6B
-7.54%
Net income
$37M
-84.90%
Profit margin
1.03%
-83.65%
Baxter Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.55
$0.68
$0.88
$0.65
-
Expected
$0.61
$0.67
$0.86
$0.61
$0.66
Surprise
-9.54%
1.84%
1.82%
7.04%
-
Baxter News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Aug
30
Baxter
Dividend·Ex-dividend
Oct
1
Baxter
Dividend·Payment
$0.29
Per share
FAQs
What’s the current market cap for Baxter stock?
Baxter (BAX) has a market cap of $18B as of July 27, 2024.
What is the P/E ratio for Baxter stock?
The price to earnings (P/E) ratio for Baxter (BAX) stock is 6.73 as of July 27, 2024.
Does Baxter stock pay dividends?
Yes, the Baxter (BAX) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $1.16 and the yield is 3.31%. Baxter has a payout ratio of 22.16% on a trailing twelve-month basis.
When is the next Baxter dividend payment date?
The next Baxter (BAX) dividend payment is scheduled for October 01, 2024.
What is the beta indicator for Baxter?
Baxter (BAX) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Baxter stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.